APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Patient Scheduling Platform

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Patient Scheduling Platform Market Outlook and Growth Opportunities 2026

Report ID 17421079045 June 2026213 pages

Choose your research edition.

Industry ResearchPatient Scheduling Platform Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Patient Scheduling Platform Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Patient Scheduling Platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Patient Scheduling Platform Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Patient Scheduling Platform Market Analysis and Forecast 2026-2032228 pages · $4,950 USD

Market perspective

The global Patient Scheduling Platform market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Patient Scheduling Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Patient Scheduling Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Patient Scheduling Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Patient Scheduling Platform market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Patient Scheduling Platform market include WellSky Scheduling, AdvancedMD, Weave, Carepatron, DoctorConnect.net, McKesson, WebPT, Yocale and Luma Health, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Patient Scheduling Platform market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Patient Scheduling Platform and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Patient Scheduling Platform revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Patient Scheduling Platform market.

Patient Scheduling Platform Segment by Company

WellSky Scheduling

AdvancedMD

Weave

Carepatron

DoctorConnect.net

McKesson

WebPT

Yocale

Luma Health

Setmore

oicent Communications

Total Recall Solutions

Mediware Information Systems

TimeTrade Systems

Relatient

Skedulo

American Medical Software

Clearwave

Upvio

TIMIFY

Nuesoft Technologies

Patient Scheduling Platform Segment by Type

Cloud-based

On-premise

Patient Scheduling Platform Segment by Application

Hospital

Specialist Clinic

Others

Patient Scheduling Platform Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Patient Scheduling Platform status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Patient Scheduling Platform key companies, revenue, market share, and recent developments.

3. To split the Patient Scheduling Platform breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Patient Scheduling Platform market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Patient Scheduling Platform significant trends, drivers, influence factors in global and regions.

6. To analyze Patient Scheduling Platform competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Patient Scheduling Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Patient Scheduling Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Patient Scheduling Platform.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Patient Scheduling Platform industry.

Chapter 3: Detailed analysis of Patient Scheduling Platform company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Patient Scheduling Platform in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Patient Scheduling Platform in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Patient Scheduling Platform Industry Trends Table 2. Patient Scheduling Platform Industry Drivers Table 3. Patient Scheduling Platform Industry Opportunities and Challenges Table 4. Patient Scheduling Platform Industry Restraints Table 5. Global Patient Scheduling Platform Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Patient Scheduling Platform Revenue Share by Company (2021-2026) Table 7. Global Patient Scheduling Platform Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Patient Scheduling Platform Key Company Manufacturing Base & Headquarters Table 9. Global Patient Scheduling Platform Company, Product Type & Application Table 10. Global Patient Scheduling Platform Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Patient Scheduling Platform by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Cloud-based Table 15. Significant Companies of On-premise Table 16. Global Patient Scheduling Platform Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Patient Scheduling Platform Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Patient Scheduling Platform Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Patient Scheduling Platform Sales Value Share by Type (2021-2026) Table 20. Global Patient Scheduling Platform Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospital Table 22. Significant Companies of Specialist Clinic Table 23. Significant Companies of Others Table 24. Global Patient Scheduling Platform Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Patient Scheduling Platform Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Patient Scheduling Platform Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Patient Scheduling Platform Sales Value Share by Application (2021-2026) Table 28. Global Patient Scheduling Platform Sales Value Share by Application (2027-2032) Table 29. Global Patient Scheduling Platform Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Patient Scheduling Platform Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Patient Scheduling Platform Sales Value Share by Region (2021-2026) Table 32. Global Patient Scheduling Platform Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Patient Scheduling Platform Sales Value Share by Region (2027-2032) Table 34. Global Patient Scheduling Platform Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Patient Scheduling Platform Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Patient Scheduling Platform Sales Value Market Share by Country (2021-2026) Table 37. Global Patient Scheduling Platform Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Patient Scheduling Platform Sales Value Market Share by Country (2027-2032) Table 39. WellSky Scheduling Company Information Table 40. WellSky Scheduling Business Overview Table 41. WellSky Scheduling Patient Scheduling Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. WellSky Scheduling Patient Scheduling Platform Product Portfolio Table 43. WellSky Scheduling Recent Development Table 44. AdvancedMD Company Information Table 45. AdvancedMD Business Overview Table 46. AdvancedMD Patient Scheduling Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. AdvancedMD Patient Scheduling Platform Product Portfolio Table 48. AdvancedMD Recent Development Table 49. Weave Company Information Table 50. Weave Business Overview Table 51. Weave Patient Scheduling Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Weave Patient Scheduling Platform Product Portfolio Table 53. Weave Recent Development Table 54. Carepatron Company Information Table 55. Carepatron Business Overview Table 56. Carepatron Patient Scheduling Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Carepatron Patient Scheduling Platform Product Portfolio Table 58. Carepatron Recent Development Table 59. DoctorConnect.net Company Information Table 60. DoctorConnect.net Business Overview Table 61. DoctorConnect.net Patient Scheduling Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. DoctorConnect.net Patient Scheduling Platform Product Portfolio Table 63. DoctorConnect.net Recent Development Table 64. McKesson Company Information Table 65. McKesson Business Overview Table 66. McKesson Patient Scheduling Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. McKesson Patient Scheduling Platform Product Portfolio Table 68. McKesson Recent Development Table 69. WebPT Company Information Table 70. WebPT Business Overview Table 71. WebPT Patient Scheduling Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. WebPT Patient Scheduling Platform Product Portfolio Table 73. WebPT Recent Development Table 74. Yocale Company Information Table 75. Yocale Business Overview Table 76. Yocale Patient Scheduling Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Yocale Patient Scheduling Platform Product Portfolio Table 78. Yocale Recent Development Table 79. Luma Health Company Information Table 80. Luma Health Business Overview Table 81. Luma Health Patient Scheduling Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Luma Health Patient Scheduling Platform Product Portfolio Table 83. Luma Health Recent Development Table 84. Setmore Company Information Table 85. Setmore Business Overview Table 86. Setmore Patient Scheduling Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Setmore Patient Scheduling Platform Product Portfolio Table 88. Setmore Recent Development Table 89. oicent Communications Company Information Table 90. oicent Communications Business Overview Table 91. oicent Communications Patient Scheduling Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. oicent Communications Patient Scheduling Platform Product Portfolio Table 93. oicent Communications Recent Development Table 94. Total Recall Solutions Company Information Table 95. Total Recall Solutions Business Overview Table 96. Total Recall Solutions Patient Scheduling Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Total Recall Solutions Patient Scheduling Platform Product Portfolio Table 98. Total Recall Solutions Recent Development Table 99. Mediware Information Systems Company Information Table 100. Mediware Information Systems Business Overview Table 101. Mediware Information Systems Patient Scheduling Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Mediware Information Systems Patient Scheduling Platform Product Portfolio Table 103. Mediware Information Systems Recent Development Table 104. TimeTrade Systems Company Information Table 105. TimeTrade Systems Business Overview Table 106. TimeTrade Systems Patient Scheduling Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. TimeTrade Systems Patient Scheduling Platform Product Portfolio Table 108. TimeTrade Systems Recent Development Table 109. Relatient Company Information Table 110. Relatient Business Overview Table 111. Relatient Patient Scheduling Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Relatient Patient Scheduling Platform Product Portfolio Table 113. Relatient Recent Development Table 114. Skedulo Company Information Table 115. Skedulo Business Overview Table 116. Skedulo Patient Scheduling Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. Skedulo Patient Scheduling Platform Product Portfolio Table 118. Skedulo Recent Development Table 119. American Medical Software Company Information Table 120. American Medical Software Business Overview Table 121. American Medical Software Patient Scheduling Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. American Medical Software Patient Scheduling Platform Product Portfolio Table 123. American Medical Software Recent Development Table 124. Clearwave Company Information Table 125. Clearwave Business Overview Table 126. Clearwave Patient Scheduling Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 127. Clearwave Patient Scheduling Platform Product Portfolio Table 128. Clearwave Recent Development Table 129. Upvio Company Information Table 130. Upvio Business Overview Table 131. Upvio Patient Scheduling Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 132. Upvio Patient Scheduling Platform Product Portfolio Table 133. Upvio Recent Development Table 134. TIMIFY Company Information Table 135. TIMIFY Business Overview Table 136. TIMIFY Patient Scheduling Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 137. TIMIFY Patient Scheduling Platform Product Portfolio Table 138. TIMIFY Recent Development Table 139. Nuesoft Technologies Company Information Table 140. Nuesoft Technologies Business Overview Table 141. Nuesoft Technologies Patient Scheduling Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 142. Nuesoft Technologies Patient Scheduling Platform Product Portfolio Table 143. Nuesoft Technologies Recent Development Table 144. Research Programs/Design for This Report Table 145. Authors List of This Report Table 146. Secondary Sources Table 147. Primary Sources List of Figures Figure 1. Patient Scheduling Platform Product Image Figure 2. Global Patient Scheduling Platform Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Patient Scheduling Platform Market Size (2021-2032) & (US$ Million) Figure 4. Global Patient Scheduling Platform Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Cloud-based Image Figure 8. On-premise Image Figure 9. Global Patient Scheduling Platform Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Patient Scheduling Platform Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Patient Scheduling Platform Sales Value Share by Type (2021-2032) Figure 12. Hospital Image Figure 13. Specialist Clinic Image Figure 14. Others Image Figure 15. Global Patient Scheduling Platform Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Patient Scheduling Platform Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Patient Scheduling Platform Sales Value Share by Application (2021-2032) Figure 18. Global Patient Scheduling Platform Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Patient Scheduling Platform Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Patient Scheduling Platform Sales Value (2021-2032) & (US$ Million) Figure 21. North America Patient Scheduling Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Patient Scheduling Platform Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Patient Scheduling Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Patient Scheduling Platform Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Patient Scheduling Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Patient Scheduling Platform Sales Value (2021-2032) & (US$ Million) Figure 27. South America Patient Scheduling Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Patient Scheduling Platform Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Patient Scheduling Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Patient Scheduling Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Patient Scheduling Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Patient Scheduling Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Patient Scheduling Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Patient Scheduling Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Patient Scheduling Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Patient Scheduling Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Patient Scheduling Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Patient Scheduling Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Patient Scheduling Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Patient Scheduling Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Patient Scheduling Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Patient Scheduling Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Patient Scheduling Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Patient Scheduling Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Patient Scheduling Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Patient Scheduling Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Patient Scheduling Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Patient Scheduling Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Patient Scheduling Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Patient Scheduling Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Patient Scheduling Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Patient Scheduling Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Patient Scheduling Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Patient Scheduling Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Patient Scheduling Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Patient Scheduling Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Patient Scheduling Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud-based
  • On-premise
Applications
  • Hospital
  • Specialist Clinic
  • Others
Companies covered
  • WellSky Scheduling
  • AdvancedMD
  • Weave
  • Carepatron
  • DoctorConnect.net
  • McKesson
  • WebPT
  • Yocale
  • Luma Health
  • Setmore
  • oicent Communications
  • Total Recall Solutions
  • Mediware Information Systems
  • TimeTrade Systems
  • Relatient
  • Skedulo
  • American Medical Software
  • Clearwave
  • Upvio
  • TIMIFY
  • Nuesoft Technologies

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Patient Scheduling Platform Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Patient Scheduling Platform Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Patient Scheduling Platform Market Dynamics
  1. 2.1 Patient Scheduling Platform Industry Trends
  2. 2.2 Patient Scheduling Platform Industry Drivers
  3. 2.3 Patient Scheduling Platform Industry Opportunities and Challenges
  4. 2.4 Patient Scheduling Platform Industry Restraints
3 Patient Scheduling Platform Market by Company
  1. 3.1 Global Patient Scheduling Platform Company Revenue Ranking in 2025
  2. 3.2 Global Patient Scheduling Platform Revenue by Company (2021-2026)
  3. 3.3 Global Patient Scheduling Platform Company Ranking (2024-2026)
  4. 3.4 Global Patient Scheduling Platform Company Manufacturing Base and Headquarters
  5. 3.5 Global Patient Scheduling Platform Company Product Type and Application
  6. 3.6 Global Patient Scheduling Platform Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Patient Scheduling Platform Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Patient Scheduling Platform Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Patient Scheduling Platform Market by Type
  1. 4.1 Patient Scheduling Platform Type Introduction
  2. 4.1.1 Cloud-based
  3. 4.1.2 On-premise
  4. 4.2 Global Patient Scheduling Platform Sales Value by Type
  5. 4.2.1 Global Patient Scheduling Platform Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Patient Scheduling Platform Sales Value by Type (2021-2032)
  7. 4.2.3 Global Patient Scheduling Platform Sales Value Share by Type (2021-2032)
5 Patient Scheduling Platform Market by Application
  1. 5.1 Patient Scheduling Platform Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Specialist Clinic
  4. 5.1.3 Others
  5. 5.2 Global Patient Scheduling Platform Sales Value by Application
  6. 5.2.1 Global Patient Scheduling Platform Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Patient Scheduling Platform Sales Value by Application (2021-2032)
  8. 5.2.3 Global Patient Scheduling Platform Sales Value Share by Application (2021-2032)
6 Patient Scheduling Platform Regional Value Analysis
  1. 6.1 Global Patient Scheduling Platform Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Patient Scheduling Platform Sales Value by Region (2021-2032)
  3. 6.2.1 Global Patient Scheduling Platform Sales Value by Region: 2021-2026
  4. 6.2.2 Global Patient Scheduling Platform Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Patient Scheduling Platform Sales Value (2021-2032)
  7. 6.3.2 North America Patient Scheduling Platform Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Patient Scheduling Platform Sales Value (2021-2032)
  10. 6.4.2 Europe Patient Scheduling Platform Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Patient Scheduling Platform Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Patient Scheduling Platform Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Patient Scheduling Platform Sales Value (2021-2032)
  16. 6.6.2 South America Patient Scheduling Platform Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Patient Scheduling Platform Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Patient Scheduling Platform Sales Value Share by Country, 2025 VS 2032
7 Patient Scheduling Platform Country-level Value Analysis
  1. 7.1 Global Patient Scheduling Platform Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Patient Scheduling Platform Sales Value by Country (2021-2032)
  3. 7.2.1 Global Patient Scheduling Platform Sales Value by Country (2021-2026)
  4. 7.2.2 Global Patient Scheduling Platform Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Patient Scheduling Platform Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Patient Scheduling Platform Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Patient Scheduling Platform Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Patient Scheduling Platform Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Patient Scheduling Platform Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Patient Scheduling Platform Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Patient Scheduling Platform Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Patient Scheduling Platform Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Patient Scheduling Platform Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Patient Scheduling Platform Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Patient Scheduling Platform Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Patient Scheduling Platform Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Patient Scheduling Platform Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Patient Scheduling Platform Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Patient Scheduling Platform Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Patient Scheduling Platform Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Patient Scheduling Platform Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Patient Scheduling Platform Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Patient Scheduling Platform Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Patient Scheduling Platform Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Patient Scheduling Platform Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Patient Scheduling Platform Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Patient Scheduling Platform Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Patient Scheduling Platform Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Patient Scheduling Platform Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Patient Scheduling Platform Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Patient Scheduling Platform Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Patient Scheduling Platform Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Patient Scheduling Platform Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Patient Scheduling Platform Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 WellSky Scheduling
  2. 8.1.1 WellSky Scheduling Company Information
  3. 8.1.2 WellSky Scheduling Business Overview
  4. 8.1.3 WellSky Scheduling Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
  5. 8.1.4 WellSky Scheduling Patient Scheduling Platform Product Portfolio
  6. 8.1.5 WellSky Scheduling Recent Developments
  7. 8.2 AdvancedMD
  8. 8.2.1 AdvancedMD Company Information
  9. 8.2.2 AdvancedMD Business Overview
  10. 8.2.3 AdvancedMD Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
  11. 8.2.4 AdvancedMD Patient Scheduling Platform Product Portfolio
  12. 8.2.5 AdvancedMD Recent Developments
  13. 8.3 Weave
  14. 8.3.1 Weave Company Information
  15. 8.3.2 Weave Business Overview
  16. 8.3.3 Weave Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Weave Patient Scheduling Platform Product Portfolio
  18. 8.3.5 Weave Recent Developments
  19. 8.4 Carepatron
  20. 8.4.1 Carepatron Company Information
  21. 8.4.2 Carepatron Business Overview
  22. 8.4.3 Carepatron Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Carepatron Patient Scheduling Platform Product Portfolio
  24. 8.4.5 Carepatron Recent Developments
  25. 8.5 DoctorConnect.net
  26. 8.5.1 DoctorConnect.net Company Information
  27. 8.5.2 DoctorConnect.net Business Overview
  28. 8.5.3 DoctorConnect.net Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
  29. 8.5.4 DoctorConnect.net Patient Scheduling Platform Product Portfolio
  30. 8.5.5 DoctorConnect.net Recent Developments
  31. 8.6 McKesson
  32. 8.6.1 McKesson Company Information
  33. 8.6.2 McKesson Business Overview
  34. 8.6.3 McKesson Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
  35. 8.6.4 McKesson Patient Scheduling Platform Product Portfolio
  36. 8.6.5 McKesson Recent Developments
  37. 8.7 WebPT
  38. 8.7.1 WebPT Company Information
  39. 8.7.2 WebPT Business Overview
  40. 8.7.3 WebPT Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
  41. 8.7.4 WebPT Patient Scheduling Platform Product Portfolio
  42. 8.7.5 WebPT Recent Developments
  43. 8.8 Yocale
  44. 8.8.1 Yocale Company Information
  45. 8.8.2 Yocale Business Overview
  46. 8.8.3 Yocale Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Yocale Patient Scheduling Platform Product Portfolio
  48. 8.8.5 Yocale Recent Developments
  49. 8.9 Luma Health
  50. 8.9.1 Luma Health Company Information
  51. 8.9.2 Luma Health Business Overview
  52. 8.9.3 Luma Health Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Luma Health Patient Scheduling Platform Product Portfolio
  54. 8.9.5 Luma Health Recent Developments
  55. 8.10 Setmore
  56. 8.10.1 Setmore Company Information
  57. 8.10.2 Setmore Business Overview
  58. 8.10.3 Setmore Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Setmore Patient Scheduling Platform Product Portfolio
  60. 8.10.5 Setmore Recent Developments
  61. 8.11 oicent Communications
  62. 8.11.1 oicent Communications Company Information
  63. 8.11.2 oicent Communications Business Overview
  64. 8.11.3 oicent Communications Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
  65. 8.11.4 oicent Communications Patient Scheduling Platform Product Portfolio
  66. 8.11.5 oicent Communications Recent Developments
  67. 8.12 Total Recall Solutions
  68. 8.12.1 Total Recall Solutions Company Information
  69. 8.12.2 Total Recall Solutions Business Overview
  70. 8.12.3 Total Recall Solutions Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Total Recall Solutions Patient Scheduling Platform Product Portfolio
  72. 8.12.5 Total Recall Solutions Recent Developments
  73. 8.13 Mediware Information Systems
  74. 8.13.1 Mediware Information Systems Company Information
  75. 8.13.2 Mediware Information Systems Business Overview
  76. 8.13.3 Mediware Information Systems Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Mediware Information Systems Patient Scheduling Platform Product Portfolio
  78. 8.13.5 Mediware Information Systems Recent Developments
  79. 8.14 TimeTrade Systems
  80. 8.14.1 TimeTrade Systems Company Information
  81. 8.14.2 TimeTrade Systems Business Overview
  82. 8.14.3 TimeTrade Systems Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
  83. 8.14.4 TimeTrade Systems Patient Scheduling Platform Product Portfolio
  84. 8.14.5 TimeTrade Systems Recent Developments
  85. 8.15 Relatient
  86. 8.15.1 Relatient Company Information
  87. 8.15.2 Relatient Business Overview
  88. 8.15.3 Relatient Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Relatient Patient Scheduling Platform Product Portfolio
  90. 8.15.5 Relatient Recent Developments
  91. 8.16 Skedulo
  92. 8.16.1 Skedulo Company Information
  93. 8.16.2 Skedulo Business Overview
  94. 8.16.3 Skedulo Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Skedulo Patient Scheduling Platform Product Portfolio
  96. 8.16.5 Skedulo Recent Developments
  97. 8.17 American Medical Software
  98. 8.17.1 American Medical Software Company Information
  99. 8.17.2 American Medical Software Business Overview
  100. 8.17.3 American Medical Software Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
  101. 8.17.4 American Medical Software Patient Scheduling Platform Product Portfolio
  102. 8.17.5 American Medical Software Recent Developments
  103. 8.18 Clearwave
  104. 8.18.1 Clearwave Company Information
  105. 8.18.2 Clearwave Business Overview
  106. 8.18.3 Clearwave Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Clearwave Patient Scheduling Platform Product Portfolio
  108. 8.18.5 Clearwave Recent Developments
  109. 8.19 Upvio
  110. 8.19.1 Upvio Company Information
  111. 8.19.2 Upvio Business Overview
  112. 8.19.3 Upvio Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Upvio Patient Scheduling Platform Product Portfolio
  114. 8.19.5 Upvio Recent Developments
  115. 8.20 TIMIFY
  116. 8.20.1 TIMIFY Company Information
  117. 8.20.2 TIMIFY Business Overview
  118. 8.20.3 TIMIFY Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
  119. 8.20.4 TIMIFY Patient Scheduling Platform Product Portfolio
  120. 8.20.5 TIMIFY Recent Developments
  121. 8.21 Nuesoft Technologies
  122. 8.21.1 Nuesoft Technologies Company Information
  123. 8.21.2 Nuesoft Technologies Business Overview
  124. 8.21.3 Nuesoft Technologies Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Nuesoft Technologies Patient Scheduling Platform Product Portfolio
  126. 8.21.5 Nuesoft Technologies Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst